Answering patient questions about women’s health can be challenging. This course walks you through topics ranging from Menopause to prevention and screening guidelines.
Package 1 – Labia & LARCs & Libido, Oh My!
LARCs: Use of Contraception Across the Lifespan (Rx=0.50)
What are some of the reasons we might start a patient on hormonal contraception? How and when in the month should they start? And what are some of the reasons you might NOT begin them? This talk will walk you through the long-acting reversible contraceptive options, risks, benefits, and efficacy, as well as placement and removal techniques. We’ll go through case studies with twists and turns representative of what we see in real life.
LGBTQIA+ Informed Health Care: Making Sense of the Letters
This discussion will offer a healthy foundation and increase familiarity with providing informed, non-biased healthcare to members of the LGBTQIA+ community. We will work through language as it applies to the LGBTQIA+ community and the additional risks and apprehensions members of this community face in relation to healthcare.
The “S” Word: Demystifying Female Sexual Health (Rx=0.50)
Female sexual health is given very little time within medical training. Here we will discuss the science behind female sexuality and address the fact that it is not merely a light version of male sexuality. For decades women have asked their medical providers to “clean out the cobwebs” while doing pelvic exams. This cry for help often remains unanswered due to, well due to so many factors – lack of time, lack of training, lack of available resources, discomfort, or bias within the topic of sexuality. Let’s debunk some of the myths. Open and transparent talk about female sexuality and how we can address this to help our patients within our daily practice.
V is for Vagina, Vestibule, Vulva – And All Things Amazing (Rx=0.50)
Often the vulva, vestibule, and vagina serve simply as a conduit to get to that cervix and screen for cancer. We are going to take a pause at these important layers discussing dermatologic disorders, vulvar and vestibular pain disorders, and recurrent vaginal infections. We will go through recognition, evaluation, and treatment of all disorders of the V!
From Menstrual Disorders to Menopause (Rx=0.25)
The span of time between menarche and menopause can be fraught with complications, from no bleeding to irregular bleeding, to heavy bleeding and all things between. PCOS, Endometriosis, Primary Ovarian Insufficiency, and PMS/PMDD are just a few of the things we will cover. Learn how to recognize and treat some of the most common menstrual disorders, as well as how to address some of the most common symptoms people endure as they approach and walk-through menopause.
Women’s Health Guidelines Update (Rx=0.25)
During this session, the epidemiology of selected conditions (breast cancer, STIs, cervical cancer, contraception, osteoporosis) will be discussed. New guidelines will be described focusing on the changes and rationale for these changes. Controversies among various guidelines will be presented and the clinical implications of these differences will be explored.
Contraceptive Update: What’s New? (Rx=1.0)
During this session, trends and contraceptive challenges facing clinicians and patients will be discussed. The new CDC medical eligibility criteria for prescribing various contraceptive methods and medical conditions will be explained. New contraceptive research regarding efficacy, risks, benefits as this pertains to prescribing will also be presented.
STI Update: Focus on the Female (Rx=0.25)
During this session the epidemiology of STIs will be discussed including recent trends and statistics. Explain diagnostic work-up for selected STIs including changes in HIV testing. Management will focus on recent changes including new gonorrhea treatment. This session will focus on the female and certain selected conditions including Herpes, CT/GC, PID, Cervicitis, HIV and Sexual Assault.
PCOS: Common, Complex and Serious (Rx=0.25)
During this session the epidemiology, complex pathophysiology, and serious associated risks and complications will be discussed. Symptoms, signs and diagnostic workup will be described. Discuss “best practice” management approaches including pharmacologic treatments and lifestyle approaches.
Menopause Alert: Hot Flashes, Vaginal Atrophy, Libido and More (Rx=0.75)
Describe epidemiology/physiology of menopause, Metabolic changes/Risks, Vasomotor Symptoms (VMS), Vulvovaginal Atrophy (VVA) and Low Libido (HSDD). Discuss the diagnosis of VMS and Vulvovaginal Atrophy. Explain pharm/non pharm options/alternatives for treatment of VMS, VVA, and Low Libido/HSDD (hypoactive sexual desire disorder).